US2023277505A1PendingUtilityA1

Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto

Assignee: ARENA PHARM INCPriority: Jul 22, 2003Filed: Dec 13, 2022Published: Sep 7, 2023
Est. expiryJul 22, 2023(expired)· nominal 20-yr term from priority
A61K 31/415C07D 231/12C07D 231/16C07D 405/12C07D 401/12A61K 31/4155A61K 31/454A61K 31/496A61K 31/5377A61P 1/04A61P 1/08A61P 1/14A61P 11/00A61P 11/06A61P 13/12A61P 19/02A61P 25/00A61P 25/02A61P 25/08A61P 25/14A61P 25/16A61P 25/18A61P 25/20A61P 25/22A61P 25/28A61P 25/32A61P 27/02A61P 29/00A61P 3/08A61P 43/00A61P 7/02A61P 7/04A61P 9/00A61P 9/10A61P 3/10
85
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to certain pyrazole derivatives of Formula (I) and pharmaceutical compositions thereof that modulate the activity of the 5-HT 2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to methods useful in the prophylaxis or treatment of platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders and the like. The present invention also relates to the method of prophylaxis or treatment of 5-HT 2A serotonin receptor mediated disorders in combination with a dopamine D2 receptor antagonist such as haloperidol, administered separately or together.

Claims

exact text as granted — not AI-modified
1 . A compound of Formula (I): 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt, hydrate or solvate thereof, 
         wherein:
 i) R 1  is aryl or heteroaryl each optionally substituted with R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15  each selected independently from the group consisting of C 1-6  acyl, C 1-6  acyloxy, C 2-6  alkenyl, C 1-6  alkoxy, C 1-6  alkyl, C 1-6  alkylcarboxamide, C 2-6  alkynyl, C 1-6  alkylsulfonamide, C 1-6  alkylsulfinyl, C 1-6  alkylsulfonyl, C 1-6  alkylthio, C 1-6  alkylureyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, C 1-6  alkylimino, carbo-C 1-6  alkoxy, carboxamide, carboxy, cyano, C 3-7  cycloalkyl, C 2-8  dialkylcarboxamide, C 2-8  dialkylsulfonamide, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, C 1-6  haloalkylsulfinyl, C 1-6  haloalkylsulfonyl, C 1-6  haloalkylthio, heterocyclic, hydroxyl, thiol, nitro, phenoxy and phenyl, or two adjacent R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15  together with the atoms to which they are attached form a C 5-7  cycloalkyl group or heterocyclic group each optionally substituted with F, Cl, or Br; and wherein said C 2-6  alkenyl, C 1-6  alkyl, C 2-6  alkynyl, C 1-6  alkylamino, C 1-6  alkylimino, C 2-8  dialkylamino, heterocyclic, and phenyl are each optionally substituted with 1 to 5 substituents selected independently from the group consisting of C 1-6  acyl, C 1-6  acyloxy, C 2-6  alkenyl, C 1-6  alkoxy, C 1-6  alkyl, C 1-6  alkylcarboxamide, C 2-6  alkynyl, C 1-6  alkylsulfonamide, C 1-6  alkylsulfinyl, C 1-6  alkylsulfonyl, C 1-6  alkylthio, C 1-6  alkylureyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, carbo-C 1-6 -alkoxy, carboxamide, carboxy, cyano, C 3-7  cycloalkyl, C 2-8  dialkylcarboxamide, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, C 1-6  haloalkylsulfinyl, C 1-6  haloalkylsulfonyl, C 1-6  haloalkylthio, hydroxyl, thiol and nitro; 
 ii) R 2  is selected from the group consisting of H, C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl and C 3-7  cycloalkyl; 
 iii) R 3  is selected from the group consisting of H, C 2-6  alkenyl, C 1-6  alkyl, C 1-6  alkylcarboxamide, C 2-6  alkynyl, C 1-6  alkylsulfonamide, carbo-C 1-6 -alkoxy, carboxamide, carboxy, cyano, C 3-7  cycloalkyl, C 2-6  dialkylcarboxamide, halogen, heteroaryl and phenyl; and wherein each of said C 2-6  alkenyl, C 1-6  alkyl, C 2-6  alkynyl, C 1-6  alkylsulfonamide, C 3-7  cycloalkyl, heteroaryl and phenyl groups can be optionally substituted with 1 to 5 substituents selected independently from the group consisting of C 1-5  acyl, C 1-5  acyloxy, C 2-6  alkenyl, C 1-4  alkoxy, C 1-8  alkyl, C 1-6  alkylamino, C 2-8  dialkylamino, C 1-4  alkylcarboxamide, C 2-6  alkynyl, C 1-4  alkylsulfonamide, C 1-4  alkylsulfinyl, C 1-4  alkylsulfonyl, C 1-4  alkylthio, C 1-4  alkylureyl, amino, carbo-C 1-6 -alkoxy, carboxamide, carboxy, cyano, C 3-6  cycloalkyl, C 2-6  dialkylcarboxamide, halogen, C 1-4  haloalkoxy, C 1-4  haloalkyl, C 1-4  haloalkylsulfinyl, C 1-4  haloalkylsulfonyl, C 1-4  haloalkylthio, hydroxyl, nitro and sulfonamide; 
 iv) R 4  is selected from the group consisting of H, C 1-6  acyl, C 1-6  acyloxy, C 2-6  alkenyl, C 1-6  alkoxy, C 1-6  alkyl, C 1-6  alkylcarboxamide, C 2-6  alkynyl, C 1-6  alkylsulfonamide, C 1-6  alkylsulfinyl, C 1-6  alkylsulfonyl, C 1-6  alkylthio, C 1-6  alkylureyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, carbo-C 1-6 -alkoxy, carboxamide, carboxy, cyano, C 3-7  cycloalkyl, C 2-8  dialkylcarboxamide, C 2-8  dialkylsulfonamide, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, C 1-6  haloalkylsulfinyl, C 1-6  haloalkylsulfonyl, C 1-6  haloalkylthio, hydroxyl, thiol, nitro and sulfonamide; 
 v) R 5  is selected from the group consisting of C 1-6  acyl, C 1-6  acyloxy, C 2-6  alkenyl, C 1-6  alkoxy, C 1-6  alkyl, C 1-6  alkylcarboxamide, C 2-6  alkynyl, C 1-6  alkylsulfonamide, C 1-6  alkylsulfinyl, C 1-6  alkylsulfonyl, C 1-6  alkylthio, C 1-6  alkylureyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, carbo-C 1-6 -alkoxy, carboxamide, carboxy, cyano, C 3-7  cycloalkyl, C 2-8  dialkylcarboxamide, C 2-8  dialkylsulfonamide, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, C 1-6  haloalkylsulfinyl, C 1-6  haloalkylsulfonyl, C 1-6  haloalkylthio, hydroxyl, thiol, nitro and sulfonamide, wherein said C 1-6  alkoxy group is optionally substituted with 1 to 5 substituents selected independently from the group consisting of C 1-5  acyl, C 1-5  acyloxy, C 2-6  alkenyl, C 1-4  alkoxy, C 1-8  alkyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, C 1-4  alkylcarboxamide, C 2-6  alkynyl, C 1-4  alkylsulfonamide, C 1-4  alkylsulfinyl, C 1-4  alkylsulfonyl, C 1-4  alkylthio, C 1-4  alkylureyl, amino, carbo-C 1-6 -alkoxy, carboxamide, carboxy, cyano, C 3-6  cycloalkyl, C 2-6  dialkylcarboxamide, halogen, C 1-4  haloalkoxy, C 1-4  haloalkyl, C 1-4  haloalkylsulfinyl, C 1-4  haloalkylsulfonyl, C 1-4  haloalkylthio, hydroxyl, nitro and phenyl, and wherein said amino and phenyl substituents are each optionally substituted with 1 to 5 further substituents selected from the group consisting of halogen and carbo-C 1-6 -alkoxy; 
 vi) R 6a , R 6b , and R 6c  are each independently selected from the group consisting of H, C 1-6  acyl, C 1-6  acyloxy, C 2-6  alkenyl, C 1-6  alkoxy, C 1-6  alkyl, C 1-6  alkylcarboxamide, C 2-6  alkynyl, C 1-6  alkylsulfonamide, C 1-6  alkylsulfinyl, C 1-6  alkylsulfonyl, C 1-6  alkylthio, C 1-6  alkylureyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, carbo-C 1-6 -alkoxy, carboxamide, carboxy, cyano, C 3-7  cycloalkyl, C 2-8  dialkylcarboxamide, C 2-8  dialkylsulfonamide, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, C 1-6  haloalkylsulfinyl, C 1-6  haloalkylsulfonyl, C 1-6  haloalkylthio, hydroxyl, thiol, nitro and sulfonamide; 
 vii) R 7  and R 8  are independently H or C 1-8  alkyl; 
 viii) X is O or S; and 
 ix) Q is C 1-3  alkylene optionally substituted with 1 to 4 substituents selected from the group consisting of C 1-3  alkyl, C 1-4  alkoxy, carboxy, cyano, C 1-3  haloalkyl, halogen and oxo; or Q is a bond. 
 
       
     
     
         2 . The compound according to  claim 1  wherein R 1  is phenyl or naphthyl each optionally substituted with R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15  each selected independently from the group consisting of C 1-6  acyl, C 1-6  alkoxy, C 1-6  alkyl, C 1-6  alkylsulfonyl, amino, C 1-5  alkylamino, C 2-8  dialkylamino, C 1-6  alkylimino, carbo-C 1-6 -alkoxy, carboxamide, carboxy, cyano, C 3-7  cycloalkyl, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, heterocyclic, hydroxyl, nitro, and phenyl, or two adjacent R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15  together with the atoms to which they are attached form a C 5-7  cycloalkyl group or heterocyclic group each optionally substituted with F; and
 wherein said C 1-6  alkyl, C 1-6  alkylimino, and heterocyclic are each optionally substituted with 1 to 5 substituents selected independently from the group consisting of C 1-6  acyl, C 1-6  alkoxy, C 1-6  alkyl, C 1-6  alkylsulfonyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, carboxamide, cyano, C 3-7  cycloalkyl, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, and hydroxyl. 
 
     
     
         3 . The compound according to  claim 1  wherein R 1  is phenyl or naphthyl each optionally substituted with R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15  each selected independently from the group consisting of C 1-6  acyl, C 1-6  alkoxy, C 1-6  alkyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, C 1-6  alkylimino, cyano, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, heterocyclic, hydroxyl, nitro, and phenyl, or two adjacent R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15  together with the atoms to which they are attached form a C 5-7  cycloalkyl group or heterocyclic group each optionally substituted with F; and wherein said C 1-6  alkyl, C 1-6  alkylimino, and heterocyclic are each optionally substituted with 1 to 5 substituents selected independently from the group consisting of C 1-6  alkyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, and hydroxyl. 
     
     
         4 . The compound according to  claim 1  wherein R 1  is phenyl or naphthyl each optionally substituted with R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15  each selected independently from the group consisting of —C(O)CH 3 , —OCH 3 , —CH 3 , —CH(CH 3 ) 2 , —CH(OH)CH 3 , —N(CH 3 ) 2 , (2-dimethylamino-ethyl)-methyl-amino, (3-dimethylamino-propyl)-methyl-amino, —C(═NOH)CH 3 , cyano, —F, —Cl, —Br, —OCF 3 , —CF 3 , 4-methyl-piperazin-1-yl, morpholin-4-yl, 4-methyl-piperidin-1-yl, hydroxyl, nitro, and phenyl. 
     
     
         5 . The compound according to  claim 1  wherein R 1  is phenyl or naphthyl each optionally substituted with R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15  each selected independently from the group consisting of —OCH 3 , —CH 3 , cyano, —F, —Cl, —Br, —OCF 3 , and —CF 3 . 
     
     
         6 . The compound according to  claim 1  wherein R 1  is heteroaryl optionally substituted with R 9 , R 10 , R 11 , R 12 , and R 13  each selected independently from the group consisting of C 1-6  acyl, C 1-6  alkoxy, C 1-6  alkyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, C 1-6  alkylimino, cyano, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, heterocyclic, hydroxyl, nitro, and phenyl, or two adjacent R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15  together with the atoms to which they are attached form a C 5-7  cycloalkyl group or heterocyclic group each optionally substituted with F; and wherein said C 1-6  alkyl, C 1-6  alkylimino, and heterocyclic are each optionally substituted with 1 to 5 substituents selected independently from the group consisting of C 1-6  alkyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, and hydroxyl. 
     
     
         7 . The compound according to  claim 1  wherein R 1  is heteroaryl optionally substituted with R 9 , R 10 , R 11 , R 12 , and R 13  each selected independently from the group consisting of —C(O)CH 3 , —OCH 3 , —CH 3 , —CH(CH 3 ) 2 , —CH(OH)CH 3 , —N(CH 3 ) 2 , (2-dimethylamino-ethyl)-methyl-amino, (3-dimethylamino-propyl)-methyl-amino, —C(═NOH)CH 3 , cyano, —F, —Cl, —Br, —OCF 3 , —CF 3 , 4-methyl-piperazin-1-yl, morpholin-4-yl, 4-methyl-piperidin-1-yl, hydroxyl, nitro, and phenyl. 
     
     
         8 . The compound according to  claim 1  wherein R 1  is heteroaryl optionally substituted with R 9 , R 10 , R 11 , R 12 , and R 13  each selected independently from the group consisting of —OCH 3 , —CH 3 , cyano, —F, —Cl, —Br, —OCF 3 , and —CF 3 . 
     
     
         9 . The compound according to  claim 1  wherein R 2  is H or C 1-6  alkyl. 
     
     
         10 . The compound according to  claim 1  wherein R 2  is selected from the group consisting of —CH 3 , —CH 2 CH 3 , —CH(CH 3 ) 2 , —CH 2 CH 2 CH 3 , —CH 2 CH(CH 3 ) 2  and —CH 2 CH 2 CH 2 CH 3 . 
     
     
         11 . The compound according to  claim 1  wherein R 2  is —CH 3  or —CH(CH 3 ) 2 . 
     
     
         12 . The compound according to  claim 1  wherein R 2  is H. 
     
     
         13 . The compound according to  claim 1  wherein R 3  is H or halogen. 
     
     
         14 . The compound according to  claim 1  wherein R 3  is H, F, Cl, or Br. 
     
     
         15 . The compound according to  claim 1  wherein R 4  is selected from the group consisting of H, C 1-6  alkyl and C 1-6  haloalkyl. 
     
     
         16 . The compound according to  claim 1  wherein R 4  is H or —CF 3 . 
     
     
         17 . The compound according to  claim 1  wherein R 5  is selected from the group consisting of C 1-6  alkoxy, C 1-6  alkylthio, amino, C 1-6  alkylamino, C 2-8  dialkylamino, halogen, C 1-6  haloalkoxy, and hydroxyl, wherein said C 1-6  alkoxy group can be optionally substituted with 1 to 5 substituents selected independently from the group consisting of amino, C 1-6  alkylamino, C 2-8  dialkylamino, amino, carbo-C 1-6 -alkoxy, carboxamide, carboxy, cyano, halogen, and phenyl, and wherein said amino and phenyl substituents are each optionally substituted with 1 to 5 further substituents selected from the group consisting of halogen and carbo-C 1-6 -alkoxy. 
     
     
         18 . The compound according to  claim 1  wherein R 5  is selected from the group consisting of C 1-6  alkoxy, C 1-6  haloalkoxy, and hydroxyl, wherein said C 1-6  alkoxy group can be optionally substituted with 1 to 5 substituents selected independently from the group consisting of amino, C 2-8  dialkylamino, carboxy, and phenyl, and wherein said amino and phenyl are each optionally substituted with 1 to 5 further substituents selected from the group consisting of halogen and carbo-C 1-6 -alkoxy. 
     
     
         19 . The compound according to  claim 1  wherein R 5  is selected from the group consisting of —OCH 3 , —OCH 2 CH 3 , —OCH(CH 3 ) 2 , —OCF 3 , hydroxyl, benzyloxy, 4-chloro-benzyloxy, phenethyloxy, 2-dimethylamino-ethoxy, 3-dimethylamino-propoxy, carboxymethoxy, and 2-tert-butoxycarbonylamino-ethoxy. 
     
     
         20 . The compound according to  claim 1  wherein R 6a , R 6b , and R 6c  are each independently selected from the group consisting of H, C 1-6  alkoxy, C 1-6  alkyl, amino, C 1-6  alkylamino, C 2-8  dialkylamino, cyano, halogen, C 1-6  haloalkoxy, C 1-6  haloalkyl, hydroxyl, and nitro. 
     
     
         21 - 54 . (canceled)

Join the waitlist — get patent alerts

Track US2023277505A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.